The company is recognized for its innovation, scientific expertise, and customer-centric clinical development model in the global biotechnology CRO market SAN ANTONIO, May 12, 2026 /PRNewswire/ ...
As Bicara Therapeutics lines up for a potential accelerated cancer drug approval next year, the biotech has appointed Chris Sarchi as its chief commercial officer. | As Bicara Therapeutics lines up ...
A Bristol-based biotech firm has made major advances towards developing a vaccine for hantavirus. EnsiliTech, based at ...
Glenmore is built in the style of a Mediterranean Spanish villa, an architectural form rarely seen in Bengaluru but adapted ...
Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase 1 ...
A phase 2 trial of Enterprise Therapeutics’ cystic fibrosis (CF) drug candidate has hit its primary endpoint, furthering the ...
A doctor by training, Matthew Goodman studied medicine in the UK before specialising in general surgery. He began his career ...
OpenSecrets reports that 17 drug companies in TrumpRx boosted lobbying by 23% to over $130M in 2025, outpacing the broader ...
Stocktwits on MSN
IBRX stock slips overnight: Founder teases Turkey push, says AI cancer cell robot is 'almost there'
Founder Patrick Soon-Shiong hinted at expansion plans in Turkey, saying on X that “Global expansion” is underway. ・Soon-Shiong also revealed that ImmunityBio’s AI-driven NK-cell manufacturing robot is ...
China has scale in engineering, in markets and in data, and a relentless focus on both research and execution – with ...
Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.
But what if one of them encounters significant competition soon? That's what some investors believe might happen, given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results